Paper39100736
Precision medicine in action for Pompe disease.
Tarallo A and 2 others. Mol Ther Nucleic Acids, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Precision medicine in action for Pompe disease. Papers, record 39100736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39100736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37421310 | Gene therapy for glycogen storage diseases. | J Inherit Metab Dis | 2024 | https://conductscience.org/library/papers/37421310 | PubMed |
| 2 | 34880218 | Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. | Nat Commun | 2021 | https://conductscience.org/library/papers/34880218 | PubMed |
| 3 | 38948331 | Base editing rescues acid α-glucosidase function in infantile-onset Pompe disease patient-derived cells. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38948331 | PubMed |
| 4 | 34506722 | Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. | Cell | 2021 | https://conductscience.org/library/papers/34506722 | PubMed |
| 5 | 31937940 | Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. | Nat Biomed Eng | 2020 | https://conductscience.org/library/papers/31937940 | PubMed |
| 6 | 22538254 | The emerging phenotype of long-term survivors with infantile Pompe disease. | Genet Med | 2012 | https://conductscience.org/library/papers/22538254 | PubMed |
| 7 | 37754285 | Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular Dystrophy. | N Engl J Med | 2023 | https://conductscience.org/library/papers/37754285 | PubMed |
| 8 | 29702637 | Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy. | Nat Biotechnol | 2018 | https://conductscience.org/library/papers/29702637 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 39859472 | Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39859472 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39100736
GET https://conductscience.org/api/papers/v1/39100736/authors